Omega Fund V GP Manager, Ltd., 10% Owner, Director at Trevi Therapeutics, Inc. (TRVI), bought 1,063,408 shares at $10.00 ($4.8M) on 2019-05-09, disclosed to the SEC on 2019-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 582,408 | $0 | 0.0% |
| 2 | $10.00 | 481,000 | $4.8M | 100.0% |
| Total | $4.52 avg | 1,063,408 | $4.8M | 100% |
| Filing → |
| NUVB | SELL | 2021-11-01 | $10.2M | — | Filing → |
| MORF | SELL | 2021-04-27 | $1.5M | — | Filing → |
| MORF | SELL | 2021-04-21 | $1.9M | — | Filing → |